Humanized chimeric antigen receptor (CAR)-modified T cells targeting CD19 induce remissions in children and young adults with relapsed/refractory lymphoblastic leukemia/lymphomaGeorge E Hucks,David M. Barrett,Susan R. Rheingold,Richard Aplenc,David T. Teachey,Colleen Callahan,Diane Baniewicz,Claire White,Mala Kiran Talekar,Pamela A. Shaw,Jennifer Brogdon,Regina M. Young,John Scholler,Katherine T. Marcucci,Anne Chew,Bruce L. Levine,Noelle Frey,David L. Porter,Simon F. Lacey,J. Joseph Melenhorst,Carl H. June,S. Grupp,Shannon L. MaudeCytotherapy(2017)引用 9|浏览39暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要